BioCentury
ARTICLE | Clinical News

Cogenzia: Ph III COACT-1 and COACT-2 data

November 22, 2016 12:39 AM UTC

Top-line data from the identical, double-blind, international Phase III COACT-1 and COACT-2 trials in a total of 1,136 patients with moderate to severe diabetic foot infections showed that up to 4 dai...

BCIQ Company Profiles

Innocoll Holdings Ltd.

BCIQ Target Profiles

Ribosomal 30S subunit